BTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BTI is a good long-term buy for a beginner with $50,000-$100,000 to invest. The stock is trading in an uptrend, sentiment from options is mildly bullish, and Morgan Stanley’s double upgrade is a strong positive signal. Since the user is impatient and wants a direct answer, my view is to buy now rather than wait for a perfect entry.
BTI’s technical setup is constructive. MACD histogram is positive at 0.24, though it is contracting, which suggests momentum is still positive but not accelerating. RSI_6 at 46.86 is neutral, so the stock is not overbought. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, which confirms an established uptrend. Price at 58.42 is just above pivot 58.558 and near support/resistance levels, with S1 at 57.522 and R1 at 59.593. Overall, the trend is bullish but not stretched.
Morgan Stanley double upgraded BTI to Overweight and named it a top pick in European tobacco, citing defensiveness, strong cash generation, and improving fundamentals from new category expansion. The broader tobacco sector also has policy-driven upside potential from possible flavored vape approvals, which could benefit large tobacco names if the regulatory environment becomes more permissive. Insiders are neutral, which avoids a negative read, and congress trading data is unavailable rather than negative.
Hedge funds are selling, with the selling amount up 180.87% over the last quarter, which is the clearest negative institutional signal. Recent news is mostly about other tobacco names rather than BTI specifically, so immediate company-specific catalysts are limited. The MACD histogram is positive but contracting, so momentum is not strengthening sharply from here.
Latest quarter financials were not provided for BTI, and the financial snapshot returned an error, so there is no usable quarter-specific revenue or earnings update to assess. Because of that, the decision relies more heavily on technicals, analyst sentiment, and sector context rather than recent quarterly growth data.
Analyst sentiment turned meaningfully positive. On 2026-04-24, Morgan Stanley double upgraded British American Tobacco to Overweight from Underweight and raised the price target to 4,900 GBp from 3,050 GBp. The firm called BAT its top pick in European tobacco, highlighting defensiveness, cash generation, and improving fundamentals. This is a strong bullish shift in Wall Street pros’ view, with the main con being that hedge funds are still selling.
